G484S Amino Acid Substitution in Lanosterol 14-α Demethylase ( ERG11 ) Is Related to Fluconazole Resistance in a Recurrent Cryptococcus neoformans Clinical Isolate

National Committee for Clinical Laboratory Standards

Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736

CLUSTAL: a package for performing multiple sequence alignment on a microcomputer

Higgins, D. G., & Sharp, P. M. (1988) · Gene · doi:10.1016/0378-1119(88)90330-7 · Cited by 3,394

Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14α-Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents

Sanglard, D., Ischer, F., Koymans, L. M. H., & Billé, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.241 · Cited by 465

Persistence of initial infection in recurrent Cryptococcus neoformans meningitis

Spitzer, E. D., Spitzer, S. G., Freundlich, L. F., & Casadevall, A. (1993) · The Lancet · doi:10.1016/0140-6736(93)90354-j · Cited by 165

Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter‐encoding gene, CnAFR1, involved in the resistance to fluconazole

Posteraro, B., Sanguinetti, M., Sanglard, D., La Sorda, M., Boccia, S., Romano, L., Morace, G., & Fadda, G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03281.x · Cited by 143

Increased Fluconazole Resistance of Cryptococcus neoformans Isolated from a Patient with AIDS and Recurrent Meningitis

Paugam, A., Dupouy‐Camet, J., Blanche, P., Gangneux, J., Tourte-Schaefer, C., & Sicard, D. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.5.975-a · Cited by 117

The G464S amino acid substitution in Candida albicans sterol 14α-demethylase causes fluconazole resistance in the clinic through reduced affinity

Kelly, S. L., Lamb, D. C., Loeffler, J., Einsele, H., & Kelly, D. E. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1136 · Cited by 116

Drug resistance in Cryptococcus neoformans

Perfect, J. R., & Cox, G. M. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0090 · Cited by 106

Multiple Resistant Phenotypes of Candida albicans Coexist during Episodes of Oropharyngeal Candidiasis in Human Immunodeficiency Virus-Infected Patients

Lopez-Ribot, J. L., McAtee, R. K., Perea, S. H., Kirkpatrick, W. R., Rinaldi, M. G., & Patterson, T. F. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1621 · Cited by 94

Fluconazole tolerance in clinical isolates of Cryptococcus neoformans

Venkateswarlu, K., Taylor, M., Manning, N. J., Rinaldi, M. G., & Kelly, S. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.748 · Cited by 75

Emergence of Triazole-Resistant Cryptococcus neoformans after Exposure to Environmentally Relevant Concentrations of Difenoconazole in Liquid Medium and Soil

Peng, W., Fu, X., Yu, H., Zhang, Y., Zhou, Q., & Cao, D. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c12837 · Cited by 6

Diagnosis of Antifungal Drug Resistance Mechanisms in Fungal Pathogens: Transcriptional Gene Regulation

Sanglard, D. (2011) · Current Fungal Infection Reports · doi:10.1007/s12281-011-0055-9 · Cited by 6

Antifungal Susceptibility of Clinical Isolates and Artificially Produced Multi-azole-resistant Strains of Cryptococcus neoformans (formerly: Cryptococcus grubii) to Ravuconazole

Kano, R., Sugita, T., & Kamata, H. (2020) · Medical Mycology Journal · doi:10.3314/mmj.19-00016 · Cited by 6

Diagnostics for human pathogenic fungal infections: Current status and future prospects

Huang, X., Moses, M., Nie, L., Wandera, E. A., & Chen, C. (2026) · hLife · doi:10.1016/j.hlife.2025.11.005 · Cited by 5

Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitis

Stott, K. E., Mohabir, J. T., Bowers, K., Tenor, J. L., Toffaletti, D. L., Unsworth, J., Jimenez‐Valverde, A., Ahmadu, A., Moyo, M., Gondwe, E., et al. (2024) · mBio · doi:10.1128/mbio.01592-24 · Cited by 5

An overview about the medical use of antifungals in Portugal in the last years

Azevedo, M. M., Cruz, L., Pina‐Vaz, C., & Rodrigues, A. G. (2016) · Journal of Public Health Policy · doi:10.1057/jphp.2016.4 · Cited by 4

What Are the Best Parents for Hybrid Progeny? An Investigation into the Human Pathogenic Fungus Cryptococcus

You, M., & Xu, J. (2021) · Journal of Fungi · doi:10.3390/jof7040299 · Cited by 5

The Ins and Outs of Azole Antifungal Drug Resistance: Molecular Mechanisms of Transport

Zavřel, M., Esquivel, B. D., & White, T. C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0667-3_29-1 · Cited by 6

In Silico Structural Modeling and Analysis of Interactions of Tremellomycetes Cytochrome P450 Monooxygenases CYP51s with Substrates and Azoles

Akapo, O. O., Macnar, J. M., Kryś, J. D., Syed, P. R., Syed, K., & Gront, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157811 · Cited by 5

Drug Resistance in Cryptococcosis

Hanson, K. E., Catania, J., Alexander, B. D., & Perfect, J. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-47266-9_20 · Cited by 4

Clinical and Mycological Features of Cryptococcosis

Kohno, S. (2003) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.44.159 · Cited by 4

Exploring Cryptococcus neoformans CYP51 and Its Cognate Reductase as a Drug Target

Ruma, Y. N., Keniya, M. V., & Monk, B. C. (2022) · Journal of Fungi · doi:10.3390/jof8121256 · Cited by 4

Resistance to Antifungal Drugs

Sanglard, D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_9 · Cited by 3

Functional Characterization of DNA N-Glycosylase Ogg1 and Ntg1 in DNA Damage Stress of Cryptococcus neoformans

Jung, K., Kwon, S., Jung, J., Lim, S., & Bahn, Y. (2023) · The Journal of Microbiology · doi:10.1007/s12275-023-00092-y · Cited by 2

In vitro effects of selective serotonin reuptake inhibitors on Cryptococcus gattii capsule and biofilm

Viveiro, L. R. D. G., Rehem, A. R., Santos, E. L. D. S., do Carmo, P. H. F., Junqueira, J. C., & Scorzoni, L. (2024) · Pathogens and Disease · doi:10.1093/femspd/ftae001 · Cited by 2

Induction of pan-azole resistance in Cryptococcus neoformans by agrochemical azole uniconazole through upregulation of efflux and chromosomal disomies

Zhang, M., Ma, W., Wang, J., Yang, F. J., Zhong, J., & Xu, Y. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1664896 · Cited by 2

Comparative evaluation of sensititre YeastOne and VITEK2 antifungal susceptibility tests with CLSI broth microdilution method of clinical Cryptococcus isolates in Taiwan

Weng, T.-P., Wang, S.-W., Lo, S.-T., Su, S.-L., Hsieh, M., Tsai, P.-J., Tsai, P.-F., Wu, C., Lee, N., Ko, W., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.02117-24 · Cited by 2

Genetic and Phenotypic Diversities in Experimental Populations of Diploid Inter-Lineage Hybrids in the Human Pathogenic Cryptococcus

You, M., Lin, Y. M., Dobrin, A., & Xu, J. (2021) · Microorganisms · doi:10.3390/microorganisms9081579 · Cited by 2

Human Fungal Pathogens and Drug Resistance Against Azole Drugs

Bhetariya, P. J., Sharma, N., Singh, P., Tripathi, P., Upadhyay, S. K., & Gautam, P. (2017) · Springer eBooks · doi:10.1007/978-3-319-48683-3_18 · Cited by 3

Fungal Drug Resistance: Azoles

Lopez-Ribot, J. L., Wiederhold, N. P., & Patterson, T. F. (2017) · Springer eBooks · doi:10.1007/978-3-319-46718-4_27 · Cited by 3

Agricultural propiconazole residues promote triazole cross-resistance in Cryptococcus neoformans through ERG11 and efflux pump overexpression

Yu, H., Peng, W., Li, H., Zhang, Y., Fu, X., Gong, X., Wei, H., Zhou, Q., Huang, Y., & Cao, D. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00765-25 · Cited by 1

Heteroresistance to fluconazole among isolates of Cryptococcus neoformans in Northern Thailand

Keerativasee, S., Khamwan, C., Boonchoo, M., Khayhan, K., Kummasook, A., Amornthipayawong, D., PrasitTharavichitkul, & Sriburee, P. (2013) · African Journal of Microbiology Research · doi:10.5897/ajmr2013.5958 · Cited by 1

Correlation of antifungal susceptibility and sequence types within Cryptococcus neoformans VNI from HIV patients, and ERG11 gene polymorphism

Zono, B., Sacheli, R., Mudogo, C. N., Kabututu, P. Z., Bontems, S., Lelo, G. M., & Hayette, M. (2023) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2023.101428 · Cited by 1

Applications of Ionic Liquids as Antimicrobials and Their Impact on Nanotechnology

Singh, H., Richu, & Kumar, A. (2024) · Springer eBooks · doi:10.1007/978-981-97-2023-1_15 · Cited by 1

Functional Genomic and Chemical Biology Analysis of Echinocandin Resistance in Candida albicans

Caplan, T. (2018) · TSpace (University of Toronto) · Cited by 1

Caracterização da atividade antifúngica de extrato aquoso de sementes de Allamanda polyantha

Bresciani, F. R. (2013) · Americanae (AECID Library)

Fungal Drug Resistance: Azoles

Lopez-Ribot, J. L., & Patterson, T. F. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-180-2_26

Utilizing a Microbial Natural Product to Investigate Cellular Circuitry Governing Fungal Drug Resistance and Morphogenesis

Shekhar‐Guturja, T. (2016) · TSpace (University of Toronto)

Current awareness on yeast

(2004) · Yeast · doi:10.1002/yea.1087

Others

Samanta, I., & Bandyopadhyay, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815770-1.00027-4

Volume 40 Number 2

(2019) · Microbiology Australia · doi:10.1071/mav40n2

Current Antifungal Drugs

Kaushik, M., Sharma, A., Gupta, S., & Gulati, P. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815080056123020008

Phenotypic and molecular antifungal susceptibility testing of yeast isolates from Pretoria

Hnaya, M. (2014) · UpSpace Institutional Repository (University of Pretoria)

True-atomic-resolution insights into the interactions of antibiotic rifampicin and rifamycin derivatives with orphan CYP143 of M.tuberculosisPreprint

Gilep, A. A., MacCarthy, C., Varaksa, T., Karpova, M., Grabovec, I. P., Karpushenkova, V. S., Kapranov, I., Sushko, T. A., Karputs, A. I., Tsumoto, K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.22.695974

Antifungal resistance: from classical mechanisms to the expanding role of acetyltransferases

Werneck, S. M. C., Gouveia‐Eufrásio, L., de Freitas, G. J. C., de Carvalho, D. S., César, I. C., Rossato, L. L., Bastos, R. W., Peres, N. T. A., & Santos, D. A. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01273-8

Dynamics associated with the efflux pumps in biofilms and persister cells of Cryptococcus neoformans and Cryptococcus gattii

Pimenta, G. R., Gualque, M. W. D. L., Siqueto, M. J., Silva, S. D. M., Regasini, L. O., Mendes‐Giannini, M. J. S., & Fusco‐Almeida, A. M. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.00203-26

Baseline fluconazole heteroresistance and risk of relapse within 6 months among patients with neurocryptococcosis in the Brazilian Amazon

Moreira, I. D. M. B., Silva, I. B., Bisneto, J. F. D. D. V., SOUSA, N. S. O. D., de Almeida, J. D. R., Filho, R. L. L. R., Lazameth-Diniz, N. D. F., Cruz, K. S., Santos, C. S. D. S., Matsuura, A. B. J., et al. (2026) · Medical Mycology · doi:10.1093/mmy/myag102

A SuperSelective primer-based real-time PCR platform for hypersensitive detection of azole resistance in Cryptococcus neoformans

Pawar, S., Xue, H. H., Wang, S., Marras, S. A. E., & Xue, C. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.01166-26

Caracterização do gene ERG11 envolvido na resistência de Cryptococcus neoformans e Cryptococcus gatti as drogas azólicas e identificação de novos alvos a partir de produtos naturais

Rossi, S. A. (2011) · Americanae (AECID Library)

Amino acid substitution in Cryptococcus neoformans lanosterol 14-α-demethylase involved in fluconazole resistance in clinical isolates

Bosco‐Borgeat, M. E., Mazza, M., Taverna, C. G., Córdoba, S. B., Murisengo, O. A., Vivot, W., & Davel, G. (2016) · Revista Argentina de Microbiología · doi:10.1016/j.ram.2016.03.003 · Cited by 33

Identification of a Cryptococcus neoformans Cytochrome P450 Lanosterol 14α-Demethylase (Erg11) Residue Critical for Differential Susceptibility between Fluconazole/Voriconazole and Itraconazole/Posaconazole

Sionov, E., Chang, Y. C., Garraffo, H. M., Dolan, M. A., Ghannoum, M. A., & Kwon-Chung, K. J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05502-11 · Cited by 123

Analyse de la sensibilité aux antifongiques des souches de Cryptococcus spp. provenant de Kinshasa (RDC), substitution intronique du gène ERG11 dans une des souches résistantes au fluconazole

Zono, B., Sacheli, R., Kabututu, P. Z., Bontems, S., Mvumbi, G. L., & HAYETTE, M.-P. (2022) · Open Repository and Bibliography (University of Liège)

S8.5d Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Colombia develop heteroresistance to fluconazole at high concentrations

Melendres, J., Carvajal, S. K., Escandón, P., & Firacative, C. (2022) · Medical Mycology · doi:10.1093/mmy/myac072.s8.5d · Cited by 2

First Isolation of Azole-Resistant Cryptococcus neoformans from Feline Cryptococcosis

Kano, R., Okubo, M., Yanai, T., Hasegawa, A., & Kamata, H. (2015) · Mycopathologia · doi:10.1007/s11046-015-9919-9 · Cited by 19